Positive opinion on Provenge
Added: Monday 22 July 2013
The Committe for Medicinal Products for Human Use (CHMP) has given a positive opinion on Provenge, for the treatment of metastatic prostate cancer. This and other news was reported in <cite>Human Medicines Highlights</cite>, the newsletter from the European Medicines Agency.
In order to be able to see the content from the www.medscape.com pages, please create first a free account at following link: